![Ironwood Pharmaceuticals to Relocate to Downtown Boston From Cambridge, to Save $25 Million - Boston Real Estate Times Ironwood Pharmaceuticals to Relocate to Downtown Boston From Cambridge, to Save $25 Million - Boston Real Estate Times](https://i0.wp.com/bostonrealestatetimes.com/wp-content/uploads/2019/06/100-summer-street-Boston.jpg?fit=398%2C600&ssl=1)
Ironwood Pharmaceuticals to Relocate to Downtown Boston From Cambridge, to Save $25 Million - Boston Real Estate Times
![Stamford Pharmaceuticals Inc has relocated its head office to Austin Texas - Stamford Pharmaceuticals Stamford Pharmaceuticals Inc has relocated its head office to Austin Texas - Stamford Pharmaceuticals](https://stamfordpharmaceuticals.com/wp-content/uploads/2021/04/news-02.jpg)
Stamford Pharmaceuticals Inc has relocated its head office to Austin Texas - Stamford Pharmaceuticals
![AgTech Accelerator: AgTech Accelerator makes first animal health industry investment in Skyline Vet Pharma with $5 million financing - Research Triangle Regional Partnership AgTech Accelerator: AgTech Accelerator makes first animal health industry investment in Skyline Vet Pharma with $5 million financing - Research Triangle Regional Partnership](https://www.researchtriangle.org/wp-content/uploads/2018/09/skyline-vet.jpg)
AgTech Accelerator: AgTech Accelerator makes first animal health industry investment in Skyline Vet Pharma with $5 million financing - Research Triangle Regional Partnership
![Venatorx Pharmaceuticals to Present at the 2019 BIO CEO & Investor Conference | VenatoRx Pharmaceuticals Venatorx Pharmaceuticals to Present at the 2019 BIO CEO & Investor Conference | VenatoRx Pharmaceuticals](https://venatorx.com/wp-content/uploads/2023/11/2019.02.06-BIO-CEO-Investor-Conference.jpg)
Venatorx Pharmaceuticals to Present at the 2019 BIO CEO & Investor Conference | VenatoRx Pharmaceuticals
![BioMarin and Skyline Therapeutics Announce Strategic Collaboration to Develop Novel Gene Therapies for Cardiovascular Diseases BioMarin and Skyline Therapeutics Announce Strategic Collaboration to Develop Novel Gene Therapies for Cardiovascular Diseases](https://mma.prnewswire.com/media/1711101/Skyline_Therapeutics.jpg?p=facebook)